トピックス別レポート一覧 その他の市場調査レポート
- 医療IT
-
- その他
- このリストは既存のカテゴリーにはいらない医療IT関連のレポートを新着順に紹介しています。
- 世界の臨床試験支援サービス市場 2022-2028
- GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028
- 価格 US$ 2,750 ｜ Triton Market Research ｜ 2022年9月 ｜ 英文レポート
- MARKET OUTLOOKTriton Market Research’s report puts forth that the global clinical trials support services market would register growth at a CAGR of 7.84% during the forecast phase of 2022-2028. The rise in the incidence of diseases has majorly increased t…
- このレポートの詳細ページはこちら
- 手術室管理ソリューション市場 - 世界の産業規模、シェア、動向、機会、予測、2017年～2027年 展開モード別（オンプレミスvsクラウド）、ソリューションタイプ別（データ管理＆通信ソリューション、麻酔情報管理システム、手術室供給管理ソリューション、手術室スケジューリングソリューション、パフォーマンス管理ソリューション、その他）、エンドユーザー別（病院、外来手術センター）、企業別、地域別で分類
- Operating Room Management Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Deployment Mode (On-Premises v/s Cloud), By Solution Type (Data Management & Communication Solutions, Anesthesia Information Management Systems, Operating Room Supply Management Solutions, Operating Room Scheduling Solutions, Performance Management Solutions, Others), By End User (Hospitals, Ambulatory Surgery Centers), By Company, and By Region
- 価格 US$ 4,900 ｜ TechSci Research ｜ 2022年12月 ｜ 英文レポート
- The global operating room management solutions market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include increasing prevalence of chronic diseases and increasing focus on improving efficiency and c…
- このレポートの詳細ページはこちら
- APACのCAD市場 2022-2026
- CAD Market in APAC 2022-2026
- 価格 US$ 2,500 ｜ TechNavio ｜ 2022年9月 ｜ 英文レポート
- Global CAD Market In APAC 2022-2026Technavio has been monitoring the CAD market in APAC and it is poised to grow by $1.92 bn during 2022-2026, accelerating at a CAGR of 8.37% during the forecast period. Our report on the CAD market in APAC provides a holi…
- このレポートの詳細ページはこちら
- 細胞・遺伝子治療の世界市場 2022-2026
- Global Cell and Gene Therapy Market 2022-2026
- 価格 US$ 2,500 ｜ TechNavio ｜ 2022年9月 ｜ 英文レポート
- Global Cell And Gene Therapy Market 2022-2026Technavio has been monitoring the cell and gene therapy market and it is poised to grow by $9.97 bn during 2022-2026, accelerating at a CAGR of 20.15% during the forecast period. Our report on the cell and gene…
- このレポートの詳細ページはこちら
- インドの工作機械市場 2022-2026
- Machine Tool Market in India 2022-2026
- 価格 US$ 2,500 ｜ TechNavio ｜ 2022年8月 ｜ 英文レポート
- Global Machine Tool Market 2022-2026Technavio has been monitoring the machine tool market and it is poised to grow by $ 2.54 bn during 2022-2026, accelerating at a CAGR of 13.04% during the forecast period. Our report on the machine tool market provides a…
- このレポートの詳細ページはこちら
- ヘルスケアIT市場。トレンド、ビジネスチャンス、競合分析
- Healthcare IT Market: Trends, Opportunities and Competitive Analysis
- 価格 US$ 4,850 ｜ Lucintel ｜ 2022年7月 ｜ 英文レポート
- Healthcare IT Market Trends and ForecastThe future of the global healthcare IT market looks promising with opportunities in the healthcare providers, hospitals, ambulatory care centers, home healthcare agencies, nursing homes, and assisted living faciliti…
- このレポートの詳細ページはこちら
- Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Glucagon Like Peptide 2 Receptor - Drugs In Development, 2022'; Glu…
- このレポートの詳細ページはこちら
- Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pr…
- このレポートの詳細ページはこちら
- C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 1…
- このレポートの詳細ページはこちら
- C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年9月 ｜ 英文レポート
- C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'C-C Chemokine Receptor T…
- このレポートの詳細ページはこちら
- Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Estrogen Receptor Beta (ER Bet…
- このレポートの詳細ページはこちら
- Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recen…
- このレポートの詳細ページはこちら
- Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
- 価格 US$ 3,500 ｜ Global Markets Direct ｜ 2022年8月 ｜ 英文レポート
- Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Retinoic Acid Receptor…
- このレポートの詳細ページはこちら
- 臨床試験支援サービスの世界市場予測 2022-2030
- GLOBAL CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 2,900 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe global clinical trials support services market is estimated to boost with a 7.65% CAGR during the assessment period, 2022-2030. The market growth is driven by the rising prevalence of chronic disease & virus outbreaks and various benefits …
- このレポートの詳細ページはこちら
- 米国臨床試験支援サービス市場予測 2022-2028
- UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2028
- 価格 US$ 1,100 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe United States clinical trials support services market is set to surge with a 7.32% CAGR during the forecast period, 2022-2028. The presence of numerous global companies and the availability of different registered studies drive the market …
- このレポートの詳細ページはこちら
- 北米の臨床試験支援サービス市場予測 2022-2030
- NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 1,600 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe North America clinical trials support services market is set to grow with a 7.20% CAGR between the forecast period, 2022 and 2030. Efficient and cost-saving technologies and the presence of numerous market players boost the market growth i…
- このレポートの詳細ページはこちら
- 欧州臨床試験支援サービス市場予測 2022-2030
- EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 1,600 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe Europe clinical trials support services market is predicted to record a 7.96% CAGR over the estimation period, 2022 and 2030. Excellent patient recruitment rates and high-quality patient data accelerate market growth in the region.MARKET I…
- このレポートの詳細ページはこちら
- アジア太平洋地域の臨床試験支援サービス市場予測 2022-2030
- ASIA-PACIFIC CLINICAL TRIALS SUPPORT SERVICES MARKET FORECAST 2022-2030
- 価格 US$ 1,600 ｜ Inkwood Research ｜ 2022年9月 ｜ 英文レポート
- KEY FINDINGSThe Asia-Pacific clinical trials support services market is estimated to surge with an 8.21% CAGR over the assessment period, 2022 and 2030. The availability of high-quality data at a low price and the presence of a huge population drive marke…
- このレポートの詳細ページはこちら
- ヘモグロビン異常症市場：タイプ別（サラセミア、鎌状赤血球症、その他）、治療法別（モノクローナル抗体薬、ACE阻害剤、ヒドロキシ尿素、その他）、流通チャネル別（病院薬局、オンラインプロバイダー、ドラッグストア、小売薬局）。世界の機会分析および産業予測、2021-2031年
- Hemoglobinopathies Market By Type (Thalassemia, Sickle Cell Disease, Others), By Therapy (Monoclonal Antibody Medication, ACE inhibitors, Hydroxyurea, Others), By Distribution Channel (Hospital Pharmacy, Online Providers, Drug Stores and Retail Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2031
- 価格 US$ 5,820 ｜ Allied Market Research ｜ 2022年7月 ｜ 英文レポート
- Hemoglobinopathy is a collective term used for the blood disorder that primarily affects the red blood cells (RBCs). The abnormal production or structural change in the hemoglobin molecule causes hemoglobinopathies. Majorly, hemoglobinopathies are divided…
- このレポートの詳細ページはこちら
- がん/腫瘍プロファイリング市場：技術（イムノアッセイ、NGS、PCR）、がんタイプ（乳がん、肺がん、大腸がん）、バイオマーカータイプ（ゲノムバイオマーカー、タンパク質バイオマーカー）、アプリケーション（バイオマーカー探索、診断、予後診断）- 2027年までの世界予測
- Cancer/Tumor Profiling Market by Technology (Immunoassay, NGS, PCR), Cancer Type (Breast, Lung, Colorectal), Biomarker Type (Genomic Biomarkers, Protein Biomarkers), Application (Biomarker Discovery, Diagnostics, Prognostics) - Global Forecast to 2027
- 価格 US$ 4,950 ｜ MarketsandMarkets ｜ 2022年11月 ｜ 英文レポート
- The global cancer/tumor profiling market is projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly driven by rising funding investments in cancer research a…
- このレポートの詳細ページはこちら
他産業の新着レポートを見る
カテゴリ別にレポートを見る
